Telix Director Adds Shares Through On-Market Purchase
Closing price · 2026-10-27: $12.79 · -0.47%
Telix Pharmaceuticals director Dr Christian Behrenbruch bought 38,750 ordinary shares on market for approximately $13 per share. His indirect holding through the Behrenbruch Family Trust increased by the same amount, while his reported direct holdings were unchanged.